一边高估值收购，一边高管大"换血"，华仁药业这次能否给深交所合理解释？|股权
2021-07-27 23:36:47ãæ¥æº: å½é
éèæ¥ ä¸¾æ¥ åäº«è³ å享è³å¥½ååæåå 7æ27æ¥æé´ï¼æ·±äº¤æååä»è¯ä¸ååºå
³æ³¨å½ï¼è¦æ±å
¬å¸è§£é说æææå¶è¯é«ä¼°å¼çåçæ§ã è®°è
注æå°ï¼7æ23æ�...
Wu Cong Sun Xiao King Li Ying Center Yichun Shenzhen Stock Exchange White Xian Qujiang New Management Committee
Source: 163.com